These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 15161801)
1. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Osei K; Rhinesmith S; Gaillard T; Schuster D Diabetes Care; 2004 Jun; 27(6):1439-46. PubMed ID: 15161801 [TBL] [Abstract][Full Text] [Related]
2. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. Osei K; Gaillard T; Schuster DP Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394 [TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone. Osei K; Gaillard T; Schuster D Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222 [TBL] [Abstract][Full Text] [Related]
4. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Osei K; Gaillard T; Schuster D Obes Res; 2005 Jan; 13(1):179-85. PubMed ID: 15761178 [TBL] [Abstract][Full Text] [Related]
5. Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants. Osei K; Schuster DP Am J Med Sci; 1996 Mar; 311(3):113-21. PubMed ID: 8615385 [TBL] [Abstract][Full Text] [Related]
6. History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African-American women with a parental history of type 2 diabetes. Osei K; Gaillard TR; Schuster DP Diabetes Care; 1998 Aug; 21(8):1250-7. PubMed ID: 9702429 [TBL] [Abstract][Full Text] [Related]
7. Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes. Osei K; Rhinesmith S; Gaillard T; Schuster D Metabolism; 2004 Apr; 53(4):414-22. PubMed ID: 15045685 [TBL] [Abstract][Full Text] [Related]
8. Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes. Osei K; Gaillard T; Kaplow J; Bullock M; Schuster D Metabolism; 2004 Dec; 53(12):1552-7. PubMed ID: 15562399 [TBL] [Abstract][Full Text] [Related]
9. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE; Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947 [TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action. Osei K; Rhinesmith S; Gaillard T; Schuster D Metabolism; 2003 May; 52(5):565-72. PubMed ID: 12759885 [TBL] [Abstract][Full Text] [Related]
11. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756 [TBL] [Abstract][Full Text] [Related]
12. [Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients]. Han XY; Ji LN; Zhou XH Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1777-80. PubMed ID: 15631772 [TBL] [Abstract][Full Text] [Related]
13. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Cnop M; Vidal J; Hull RL; Utzschneider KM; Carr DB; Schraw T; Scherer PE; Boyko EJ; Fujimoto WY; Kahn SE Diabetes Care; 2007 Mar; 30(3):677-82. PubMed ID: 17327340 [TBL] [Abstract][Full Text] [Related]
14. Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels. Ebenibo S; Edeoga C; Wan J; Dagogo-Jack S Metabolism; 2014 Jun; 63(6):767-72. PubMed ID: 24641885 [TBL] [Abstract][Full Text] [Related]
15. Natural history of impaired glucose tolerance: follow-up at Joslin Clinic. Warram JH; Sigal RJ; Martin BC; Krolewski AS; Soeldner JS Diabet Med; 1996 Sep; 13(9 Suppl 6):S40-5. PubMed ID: 8894480 [TBL] [Abstract][Full Text] [Related]
16. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S; J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736 [TBL] [Abstract][Full Text] [Related]
17. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance. Viswanathan V; Clementina M; Nair BM; Satyavani K J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128 [TBL] [Abstract][Full Text] [Related]
18. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM. Motala AA; Omar MA; Gouws E Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Shalitin S; Abrahami M; Lilos P; Phillip M Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115 [TBL] [Abstract][Full Text] [Related]
20. Insulin sensitivity and secretion in Arab Americans with glucose intolerance. Salinitri FD; Pinelli NR; Martin ET; Jaber LA Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]